87
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Endocrine Active Compounds: From Biology to Dose Response Assessment

Pages 363-423 | Published online: 29 Sep 2008

REFERENCES

  • McLachlan, J.A. and Korach, K.S., Symposium on Estrogens in the Environment. III.G.obal Health Implications, Environ. Health Perspect., 1995; 103: 3–4.
  • Colborn, T., Dumanoski, D., and Myers, J.P., Our Stolen Future: Are We Threatening Our Fertility, Intelligence, and Survival?—A Scientific Detective Story, New York: Penguin Books USA, Inc., 1996.
  • Hileman, B., Environmental Hormone Disrupters Focus of Major Research Initiatives. Chem. Engineer. News, 1996; 74: 2835.
  • Carr, C.J. and Wilkinson, C.F., Assessing the Risks of Adverse Endocrine-Mediated Effects. Regul. Toxicol. Pharmacol, 1997; 26: 7–8.
  • LeBlanc, G.A., Are Environmental Sentinels Signaling? Environ. Health Perspect., 1995; 103: 888–890.
  • Daston, G.P., Gooch, J.W., Breslin, W.J., Shuey, D.L., Nikiforov, A.I., Fico, T.A., and Gorsuch, J.W., Environmental Estrogens and Reproductive Health: A Discussion of the Human and Environmental Data. Reprod. Toxicol., 1997; 11: 465–481.
  • Giusti, R.M., Iwamoto, K., and Hatch, E.E., Diethylstilbestrol Revisited: A Review of the Long-Term Health Effects. Ann. Intern. Med., 1995; 122: 778–788.
  • Newbold, R.R. and McLachlan, J.A., Trans- placental Hormonal Carcinogenesis: Diethyl- stilbestrol as an Example, In:, Huff, J., Boyd, J. and Barrett, J.C., Eds. Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences. New York: Wiley-Liss, Inc., 1996, 131–147.
  • Mittendorf, R., Teratogen Update: Carcino- genesis and Teratogenesis Associated with Exposure to Diethylstilbestrol DES. In Utero. Teratology, 1995; 51: 435–445.
  • EPA, Drinking Water Criteria Document for Polychlorinated Biphenyls PCBs., ECAO- CIN-414, Office of Research and Development: Cincinnati, OH, 1988.
  • Henderson, B.E., Ross, R.K., and Pike, M.C., Hormonal Chemoprevention of Cancer in Women. Science, 1993; 259: 633–638.
  • Adlercreutz, H., Phytoestrogens: Epidemiology and a Possible Role in Cancer Protection. Environ. Health Perspect., 1995; 103: 103–112.
  • Black, L.J., Sata, M., Rowley, E.R., Magee, D.E., Bekele, A., Williams, D.C., Cullinan, G.J., Bendele, R., Kauffman, R.F., and Bensch, W.R., Raloxifene LY139481 HCl. Prevents Bone Loss and Reduces Serum Cholesterol Without Causing Uterine Hypertophy in Ovariectomized Rats. J. Clin. Invest., 1994; 93: 63–69.
  • Ashby, J., Odum, J., Tinwell, H., and Lefevre, P.A., Assessing the Risks of Adverse Endocrine-Mediated Effects: Where to from Here? Regul. Toxicol. Pharmacol., 1997; 26: 80–93.
  • Fenner-Crisp, P.A., Endocrine Disruptor Risk Characterization: An EPA Perspective. Regul. Toxicol. Pharmacol., 1997; 26: 70–73.
  • Crowley, W.F., Whitcomb, R.W., Jameson, J.L., Weiss, J., Finkelstein, J.S., and O'Dea, L.S.L., Neuroendocrine Control of Human Reproduction in the Male. Recent Prog. Horm. Res., 1991; 47: 27–67.
  • DeGroot, L.J., Ed. Endocrinology. Philadelphia: W.B. Saunders Co., 1995.
  • Freeman, M.E., The Neuroendocrine Control of the Ovarian Cycle of the Rat, In:, Knobil, E. and Neill, J.D., Eds. The Physiology ofReproduction, 2nd Edition. New York: Raven Press, Ltd., 1994, 613–658.
  • Hotchkiss, J. and Knobil, E., The Menstrual Cycle and Its Neuroendocrine Control, In:, Knobil, E. and Neill, J.D., Eds. The Physiology ofReproduction. New York: Raven Press, Ltd., 1994, 711–749.
  • Muller, E.E., Role of Neurotransmitters and Neuromodulators in the Control of Anterior Pituitary Hormone Secretion, In: DeGroot, L.J., Ed, Endocrinology. Philadelphia: W.B. Saunders Co., 1995, 178–191.
  • Hillier, S.G., Intraovarian Steroid Action, In: Hochberg, R.B. and Naftolin, F., Eds., The New Biology ofSteroid Hormones. New York: Raven Press, 1991, 227–234.
  • DePaolo, L.V., Bicsak, T.A., Erickson, G.F., Shimasaki, S., and Ling, N., Follistatin and Activin: A Potential Intrinsic Regulatory System within Diverse Tissues. Proc. Soc. Exp. Biol. Med, 1991; 198: 500–512.
  • Mather, J.P., Woodruff, T.K., and Krummen, L.A., Paracrine Regulation of Reproductive Function by Inhibin and Activin. Proc. Soc. Exp. Biol. Med., 1992; 201: 1–15.
  • Vander, A.J., Sherman, J.H., and Luciano, D.S., Human Physiology. The Mechanisms of Body Function, New York: McGraw-Hill, Inc., 1994.
  • Bocos, C., Gottlicher, M., Gearing, K., Banner, C., Enmark, E., Teboul, M., Crickmore, A., and Gustafsson, J.-A., Fatty Acid Activation of Peroxisome Proliferator- Activated Receptor PPAR.. J. Steroid Biochem. Mol. Biol., 1995; 53: 467–473.
  • Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R.M., The Nuclear Receptor Superfamily: The Second Decade. Cell, 1995; 83: 835–839.
  • Shibata, H., Spencer, T.E., Onate, S.A., Jenster, G., Tsai, S.Y., Tsai, M.-J., and O'Malley, B.W., Role of Co-activators and Co-repressors in the Mechanism of Steroid/ Thyroid Receptor Action. Recent Prog. Horm. Res., 1997; 52: 141–165.
  • Barton, H.A., Andersen, M.E., and Clewell, H.J., III, Harmonization: Developing Consistent Guidelines for Applying Mode of Action and Dosimetry Information to Cancer and Noncancer Risk Assessment. Hum. Ecol. Risk Assess., 1998; in press.
  • NRC, Risk Assessment in the Federal Government: Managing the Process, Washington, D.C.: NAS Press, 1983.
  • NRC, Science and Judgement in Risk Assessment, Washington, D.C.: NAS Press, 1994.
  • EPA, Proposed Guildlines for Carcinogen RiskAssessment, EPA 600-P-92-003C, Washington, D.C.: Office of Research and Development, 1996.
  • EPA, Guidelines for Reproductive Toxicity Risk Assessment, EPA/630/R-96/009, Washington, D.C.: Office of Research and Development, 1996.
  • Clewell, H.J., III and Andersen, M.E., Dose, Species, and Route Extrapolation Using Physiologically Based Pharmacokinetic Models. In: Pharmacokinetics in Risk Assessment: Drinking Water and Health. Washington, D.C.: National Academy Press, 1987, 159–182.
  • Clewell, H.J. and Andersen, M.E., Biologically Motivated Models for Chemical Risk Assessment. Health Physiol, 1989; 57: 129137.
  • Clewell, H.J., III and Andersen, M.E., Use of Physiologically Based Phamracokinetic Modeling to Investigate Individual Versus Population Risk. Toxicology, 1996; 111: 315329.
  • Bois, F.Y., Krowech, G., and Zeise, L., Modeling Human Interindividual Variability in Metabolism and Risk: The Example of 4- Aminobiphenyl. Risk Anal., 1995; 15: 205213.
  • Leung, H.-W., Development and Utilization of Physiologically Based Pharmacokinetic Models for Toxicological Applications. J. Toxicol. Environ. Health, 1991; 32: 247–267.
  • EPA, Proposed Guidelines for Carcinogen Risk Assessment, EPA 600-P-92-003C, Washington, D.C.: Office of Research and Development, 1996.
  • NRC, Biologic Markers in Reproductive Toxicology, Washington, D.C.: National Research Council, National Academy Press, 1989.
  • Jusko, W.J., Receptor-Mediated Pharmaco- dynamics of Corticosteroids. In: Receptor- Mediated Processes: Implications for Evaluating Carcinogenesis. New York: Wiley-Liss, Inc., 1994, 261–270.
  • Leung, H.W., Paustenbach, D.J., Murray, F.J., and Andersen, M.E., A Physiological Pharmacokinetic Description of the Tissue Distribution and Enzyme Inducing Properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the Rat. Toxicol. Appl. Pharmacol, 1990; 103: 399–410.
  • O'Flaherty, E.J., Interspecies Conversion of Kinetically Equivalent Doses. Risk Anal., 1989; 9: 587–598.
  • Andersen, M.E., What Do We Mean By . Dose? Inhal. Toxicol., 1995; 7: 909–915.
  • Hattis, D. and Shapiro, K., Analysis of Dose/ Time/Response Relationships for Chronic Toxic Effects—The Case of Acrylamide. NeuroToxicology, 1990; 11: 219–236.
  • Gray, L.E., Jr., Chemical-Induced Alterations of Sexual Differentiation: A Review of Effects in Humans and Rodents, In: Colborn, T. and Clement, C., Eds. Chemically-Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connections. Princeton, NJ: Princeton Scientific Publishing Co., Inc., 1992, 203–230.
  • Jones, L.A. and Hajek, R.A., Effects of Estrogenic Chemicals on Development. Environ. Health Perspect., 1995; 103: 63–67.
  • Hines, M., Surrounded by Estrogens? Considerations for Neurobehavioral Development in Human Beings, In: Colborn, T. and Clement, C., Eds. Chemically-Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton, NJ: Princeton Scientific Publishing Co., Inc., 1992, 261–282.
  • Mahesh, V.B., Brann, D.W., and Hendry, L.B., Diverse Modes of Action of Progesterone and its Metabolites. J. Steroid Biochem. Mol. Biol., 1996; 56: 209–219.
  • EPA, Guidelines for Reproductive Toxicity Risk Assessment, EPA/600/AP-94/001, Office of Research and Development: Washington, D.C., 1994.
  • EPA, Proposed Guidelines for Neurotoxicity Risk Assessment; Notice. Fed. Regist., 1995; 60: 52032–52056.
  • Chapin, R.E., Harris, M.W., Davis, B.J., Ward, S.M., Wilson, R.E., Mauney, M.A., Lockhart, A.C., Smialowicz, R.J., Moser, V.C., Burka, L.T., and Collins, B.J., The Effects of Perinatal/Juvenile Methoxychlor Exposure on Adult Rat Nervous, Immune, and Reproductive System Function. Fundam. Appl. Toxicol., 1997; 40: 138–157.
  • Higgins, I.T.T., What is an Adverse Health Effect? J. Air Poll. Cont. Assoc., 1983; 33: 661–663.
  • Hattis, D., Use of Biological Markers and Pharmacokinetics in Human Health Risk Assessment. Environ. Health Perspect., 1991; 90: 229–238.
  • Safe, S.H., Environmental and Dietary Estrogens and Human Health: Is There a Problem? Environ. Health Perspect., 1995; 103: 346351.
  • Bradlow, H.L., Davis, D.L., Lin, G., Sepkovic, D., and Tiwari, R., Effects of Pesticides on the Ratio of 16a/2-Hydroxy- estrone: A Biologic Marker of Breast Cancer Risk. Environ. Health Perspect., 1995; 103: 147–150.
  • D'Souza, R.W., Francis, W.R., and Andersen, M.E., A Physiological Model for Tissue Glutathione Depletion and Increased Resynthesis after Ethylene Dichloride Exposure. J. Pharmacol. Exp. Ther., 1988; 245: 563–568.
  • Conolly, R.B., Morgan, K.T., Andersen, M.E., Monticello, T.M., and Clewell, H.J., A Biologically Based Risk Assessment Strategy for Inhaled Formaldehyde. Toxicol. Lett, 1992; 4: 269–293.
  • Conolly, R.B., Reitz, R.H., Clewell, H.J., and Andersen, M.E., Pharmacokinetics, Biochemical Mechanism and Mutation Accumulation: A Comprehensive Model of Chemical Carcinogenesis. Toxicol. Lett, 1988; 43: 189200.
  • Wetzel, L.T., Luempert, L.G., Breckenridge, C.B., Tisdel, M.O., Stevens, J.T., Thakur, A.K., Extrom, P.J., and Eldridge, J.C., Chronic Effects of Atrazine on Estrus and Mammary Tumor Formation in Female Sprague-Dawley and Fischer 344 Rats. J. Toxicol. Environ. Health, 1994; 43: 169–182.
  • Stevens, J.T., Breckenridge, C.B., Wetzel, L.T., Gillis, J.H., Luempert, L.G., III, and Eldridge, J.C., Hypothesis for Mammary Tumorigenesis in Sprague-Dawley Rats Exposed to Certain Triazine Herbicides . J. Toxicol. Environ. Health, 1994; 43: 139–153.
  • Cooper, R.L., Stoker, T.E., Goldman, J.M., Hein, J., and Tyrey, L., Atrazine Disrupts Hypothalamic Control of Pituitary-Ovarian Function. Fundam. Appl. Toxicol., 1996; 30: Abst# 339.
  • Cooper, R.L., Stoker, T.E., Goldman, J.M., Parrish, M.B., and Tyrey, L., Effects of Atrazine on Ovarian Function in the Rat. Reprod. Toxicol, 1996; 10: 257–264.
  • Colborn, T., vom Saal, F.S., and Soto, A.M., Developmental Effects of Endocrine-Disrupting Chemicals in Wildlife and Humans. Environ. Health Perspect, 1993; 101: 378384.
  • Mori, T., Abnormalities in the Reproductive System of Aged Mice after Neonatal Estra- diol Exposure. J. Endocrinol, 1986; 9: 397402.
  • Guillette, L.J., Jr., Drain, D.A., Rooney, A.A., and Pickford, D.B., Organization Versus Activation: The Role of Endocrine-Disrupting Contaminants EDCs. During Embryonic Development in Wildlife. Environ. Health Perspect, 1995; 103: 157–164.
  • Yamamoto, K.R., Steroid Receptor Regulated Transcription of Specific Genes and Gene Networks. Annu. Rev. Genet., 1985; 19: 209–252.
  • Francis, E.Z. and Kimmel, G.L., Proceedings of the Workshop on One- vs. Two- Generation Reproductive Effects Studies. J. Am. Coll. Toxicol., 1988; 7: 911–925.
  • Stevens, J.T., Tobia, A., Lamb, J.C., IV, Tellone, C., and O'Neal, F., FIFRA Subdivision F Testing Guidelines: Are These Tests Adequate to Detect Potential Hormonal Activity for Crop Protection Chemical? J. Toxicol. Environ. Health, 1997; 50: 415431.
  • EPA, Toxic Substances Control Act Test Guidelines. Fed. Regis., 1997; 62: 43820.
  • vom Saal, F.S., Finch, C.E., and Nelson, J.F., Natural History and Mechanisms of Reproductive Aging in Humans, Laboratory Rodents and Other Selected Vertebrates, In: Knobil, E. and Neill, J.D., Eds., The Physiology of Reproduction, Second Edition. New York: Raven Press, Ltd., 1994, 1213–1313.
  • Fry, D.M. and Toone, C.K., DDT-Induced Feminization of Gull Embryos. Science, 1981; 213: 922–924.
  • Fry, D.M., Reproductive Effects in Birds Exposed to Pesticides and Industrial Chemicals. Environ. Health Perspect., 1995; 103: 165–171.
  • Barrett, J., Phytoestrogens Friends or Foes? Environ. Health Perspect., 1996; 104: 478482.
  • Tolman, J., Nature's Hormone Factory: Endocrine Distrupters in the Natural Environment, Washington, D.C.: Competitive Enterprise Institute, 1996.
  • Barton, H.A. and Andersen, M.E., Dose- Response Assessment Strategies for Endocrine-Active Compounds. Regul. Toxicol. Pharmacol., 1997; 25: 292–305.
  • Kavlock, R.J., Daston, G.P., DeRosa, C., Fenner-Crisp, P., Gray, L.E., Kaattari, S., Lucier, G., Luster, M., Mac, M.J., Maczka, C., Miller, R., Moore, J., Rolland, R., Scott, G. , Sheehan, D.M., Sinks, T., and Tilson, H.A., Research Needs for the Risk Assessment of Health and Environmental Effects of Endocrine Disruptors: A Report of the U.S. EPA-Sponsored Workshop. Environ. Health Perspect, 1996; 104: 715–740.
  • Sharpe, R.M. and Skakkebaek, N.E., Are Oestrogens Involved in Falling Sperm Counts and Disorders of the Male Reproductive Tract? Lancet, 1993; 341: 1392–1395.
  • Gray, L.E., Jr., Ostby, J.S., and Kelce, W.R., Developmental Effects of an Environmental Antiandrogen: The Fungicide Vinclo- zolin Alters Sex Differentiation of the Male Rat. Toxicol. Appl. Pharmacol., 1994; 129: 46–52.
  • Kelce, W.R., Lambright, C.R., Gray, L.E., Jr., and Roberts, K.P., Vinclozolin and p,p'- DDE Alter Androgen-Dependent Gene Expression: In Vivo Confirmation of an Andro- gen Receptor-Mediated Mechanism. Toxicol. Appl. Pharmacol., 1997; 142: 192–200.
  • de Kretser, D.M., Risbridger, G.P., and Kerr, J.B., Basic Endocrinology of the Tes- tes, In: DeGroot, L.J., Ed. Endocrinology. Philadelphia: W.B. Saunders, 1995, 23072335.
  • Luke, M.C. and Coffey, D.S., The Male Sex Accessory Tissues, In: Knobil, E., and Neill, J.D., Eds. The Physiology of Reproduction, Second Edition. New York: Raven Press, Ltd., 1994, 1435–1487.
  • Hsueh, A.J.W. and Billig, H., Ovarian Hormone Synthesis and Mechanism of Action, In: DeGroot, L.J., Ed. Endocrinology. Philadelphia: W.B. Saunders Company, 1995, 2019–2030.
  • Handelsman, D.J., Testosterone and Other Androgens: Physiology, Pharmacology and Therapeutic Use, In: DeGroot, L.J., Ed., Endocrinology. Philadelphia: W.B. Saunders Co., 1995, 2351–2361.
  • Omura, T. and Morohashi, K.-i., Gene Regulation of Steroidogenesis. J. Steroid Biochem. Mol. Biol., 1995; 53: 19–25.
  • Hall, P.F., Testicular Steroid Synthesis: Organization and Regulation, In: Knobil, E. and Neill, J.D., Eds., The Physiology of Reproduction. New York: Raven Press, Ltd., 1994, 1335–1362.
  • Clark, J.H. and Markaverich, B.M., The Agonistic and Antagonistic Effects of Short Acting Estrogens: A Review. Pharmacol. Ther., 1983; 21: 429–453.
  • Preslock, J.P., Steroidogenesis in the Normal and Abnormal Human Testis, In: Fotherby, K. and Pal, S.B., Eds. Steroid Converting Enzymes and Diseases. Berlin - New York: Walter de Gryter & Co., 1984, 73–96.
  • Burger, H.G., Gonadal Regulatory Peptides, In: DeGroot, L.J., Ed., Endocrinology. Philadelphia: W.B. Saunders Co., 1995, 20082018.
  • Clark, J.H. and Mani, S.K., Actions of Ovarian Steroid Hormones, In: Knobil, E. and Neill, J.D., Eds. The Physiology of Reproduction. New York: Raven Press, Ltd., 1994, 1011–1059.
  • Clark, J.H. and Peck, E.J., Jr., Female Sex Steroids, New York: Springer-Verlag, 1979.
  • Clemm, D.L., Macy, B.L., Santiso-Mere, D., and McDonnell, D.P., Definition of the Critical Cellular Components Which Distinguish Between Hormone and Antihormone Activated Progesterone Receptor. J. Steroid Biochem.. Mol. Biol., 1995; 53: 487–495.
  • Korach, K.S., Insights from the Study of Animals Lacking Functional Estrogen Receptor. Science, 1994; 266: 1524–1527.
  • Landers, J.P. and Spelsberg, T.C., New Concepts in Steroid Hormone Action: Transcription Factors, Proto-Oncogenes, and the Cascade Model for Steroid Regulation of Gene Expression. Crit. Rev. Eukary. Gene Exp., 1992; 2: 19–63.
  • Kuiper, G.G., Enmark, D., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J.A., Cloning of a Novel Receptor Expressed in Rat Prostate and Ovary. Proc. Natl. Acad. Sci. USA, 1996; 93: 5925–5930.
  • Kuiper, G.G.J.M., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J.-A., Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors a and b. Endocrinology, 1997; 138: 863870.
  • Ciocca, D.R. and Vargas Roig, L.M., Estrogen Receptors in Human Nontarget Tissues: Biological and Clinical Implications. Endocr. Rev., 1995; 16: 35–62.
  • Gammeltoft, S. and Kahn, C.R., Hormone Signaling Via Membrane Receptors, In: DeGroot, L.J., Ed., Endocrinology. Philadelphia: W.B. Saunders, Co., 1995, 17–65.
  • Lincoln, D.W., Gonadotropin-Releasing Hormone GnRH.: Basic Physiology, In: DeGroot, L.J., Ed., Endocrinology. Philadelphia: W.B. Saunders, Co., 1995, 218–241.
  • Waxman, D.J., Pampori, N.A., Ram, P.A., Agrawal, A.K., and Shapiro, B.H., Interpulse Interval in Circulating Growth Hormone Patterns Regulates Sexually Dimorphic Expression of Hepatic Cytochrome P450. Proc. Natl. Acad. Sci. USA, 1991; 88: 6868–6872.
  • Farnworth, P.G., Gondotrophin Secretion Revisited. How Many Ways Can FSH Leave a Gonadotoph? J. Endocrinol, 1995; 145: 387–395.
  • Muyan, M., Zyzmkiewicz, D.M., and Boime, I., Secretion of Lutropin and Follitropin from Transfected BH3 Cells: Evidence for Separate Secretory Pathways. Mol. Endocrinol., 1994; 8: 1789–1797.
  • Andrews, W.W. and Ojeda, S.R., On the Feedback Actions of Estrogen on Gonadotro- pin and Prolactin Release in Infantile Female Rats. Endocrinology, 1977; 101: 1517–1523.
  • Renoir, J.M., Mercier-Bodard, C., and Baulieu, E.-E., Hormonal and Immunologi- cal Aspects of the Phylogeny of Sex Steroid Binding Plasma Protein. Proc. Natl. Acad. Sci. USA, 1980; 77: 4578–4582.
  • Rosner, W., Plasma Steroid-Binding Proteins. Endocrinol. Metab. Clin. NA, 1991; 20: 697720.
  • Wu, A.H., Whittemore, A.S., Kolonel, L.N., John, E.M., Gallagher, R.P., West, D.W., Hankin, J., Teh, C.Z., Dreon, D.M., and Paffenbarger, R.S., Jr., Serum Androgens and Sex Hormore-Binding Globulins in Relation to Lifestyle Factors in Older African- American, White and Asian Men in the United State and Canada. Cancer Epidemiol. Biomarkers Prev, 1995; 4: 735–741.
  • Danzo, B.J., The Effects of a Gonadotropin- Releasing Hormone Antagonist on Andro- gen-Binding Protein Distribution and Other Parameters in the Adult Male Rat. Endocrinology, 1995; 136: 4004–4011.
  • Keefe, D., Garcia-Segura, L.M., and Naftolin, F., New Insights into Estrogen Action on the Brain. Neurobiol. Aging, 1994; 15: 495–497.
  • Whitten, P.L. and Naftolin, F., Xenoestro- gens and Neuroendocrine Development, In: Needleman, H.L. and Bellinger, D., Eds., Prenatal Exposure to Toxicants. Developmental Consequences. Baltimore: The Johns Hopkins University Press, 1994, 268–293.
  • Culler, M.D. and Negro-Vilar, A., Endogenous Inhibin Suppresses Only Basal Follicle-Stimulating Hormone Secretion but Suppresses All Paramters of Pulsatile Luteinizing Hormone Secretion in Diestrous Female Rat. Endocrinology, 1989; 124: 2944–2953.
  • Illingworth, P.J., Groome, N.P., Byrd, W., Rainey, W.E., McNeilly, A.S., Mather, J.P., and Bremner, W.J., Inhibin-B: A Likely Candidate for the Physiologically Important Form of Inhibin in Men. J. Clin. Endocrinol. Metab., 1996; 81: 1321–1325.
  • Hermans, W.P., van Leeuwen, E.C.M., Debets, M.H.M., and de Jong, F.H., Involvement of Inhibin in the Regulation of Follicle-Stimulating Hormone Concentrations in Prepubertal and Adult, Male and Female Rats. J. Endocrinol, 1980; 86: 79–92.
  • Culler, M.D. and Negro-Vilar, A., Passive Immunoneutralization of Endogenous Inhibin: Sex-Related Differences in the Role of Inhbin During Development. Mol. Cell. Endocrinol., 1988; 58: 263–273.
  • Sharpe, R.M. and Maddocks, S., Evaluation of the Relative Importance of Endocrine and Paracrine Factors in Control of the Levels of Inhibin in Testicular Interstitial Fluid. Int. J. Androl., 1989; 12: 295–306.
  • Andersen, M.E., Clewell, J.H., III, Gearhart, J., and Allen, B.C., A Pharmaco- dynamic Model of the Rat Estrus Cycle in Relation to Endocrine Disruptors. J. Toxicol. Environ. Health, 1997; 51: 189–209.
  • George, F.W. and Wilson, J.D., Sex Determination and Differentiation. In: Knobil, E. and Neill, J.D., Eds. The Physiology of Reproduction. New York: Raven Press, Ltd., 1994, 3–28.
  • Ojeda, S.R., Urbanski, H.F., and Ahmed, C.E., The Onset of Female Puberty: Studies in the Rat. Recent Prog. Horm. Res., 1986; 42: 385–442.
  • Makela, S., Santti, R., Salo, L., and McLachlan, J.A., Estrogen-Specific 17b- Hydroxysteroid Oxidoreductase Type 1E.C. 1.1.1.61. as a Possible Target for the Action of Phytoestrogens. Proc. Soc. Exp. Biol. Med., 1995; 208: 51–59.
  • Wang, C., Makela, T., Hase, T., Adler- creutz, H., and Kruzer, M.S., Lignans and Flavonoids Inhibit Aromatase Enzyme in Human Preadipocytes. J. Steroid Biochem. Mol. Biol., 1994; 50: 205–212.
  • Treinen, K.A., Dodson, W.C., and Heindel, J.J., Inhibition of FSH-Stimulated cAMP Accumulation and Progesterone Production by Mono2-ethylhexyl. Phthalate in Rat Granu- losa Cell Cultures. Toxicol. Appl. Pharmacol., 1990; 106: 334–340.
  • Davis, B.J., Maronpot, R.R., and Heindel, J.J., Di-2-ethylhexyl. Phthalate Suppresses Es- tradiol and Ovulation in Cycling Rats. Toxicol. Appl. Pharmacol, 1994; 128: 216–223.
  • Davis, B.J., Weaver, R., Gaines, L.J., and Heindel, J.J., Mono-2-ethylhexyl. Phthalate Suppresses Estradiol Production Independent of FSH-cAMP Stimulation in Rat Granulosa Cells. Toxicol. Appl. Pharmacol., 1994; 128: 224–228.
  • ATSDR, Toxicological Profile for Diethyl- hexylphthalates, 1995, Springfield, VA: US Department of Health and Human Services, 1995.
  • Parmar, D., Srivastava, S.P., Singh, G.B., and Seth, P.K., Testicular Toxicity of Di2- Ethylhexyl. Phthalate in Developing Rats. Vet. Hum. Toxicol., 1995; 37: 310–313.
  • Stancel, G.M., Boettger-Tong, H.L., Chiappetta, C., Hyder, S.M., Kirkland, J.L., Murthy, L., and Loose-Mitchell, D.S., Tox- icity of Endogenous and Environmental Estrogens: What is the Role of Elemental Interactions? Environ. Health Perspect., 1995; 103: 29–33.
  • Campbell, P.S., Impaired Prepubertal Uterine Responsivity After Neonatal Exposure to Steroid Hormone Esters. J. Exp. Zool., 1980; 214: 345–353.
  • Markaverich, B.M., Webb, B., Densmore, C.L., and Gregory, R.R., Effects of Coumestrol on Estrogen Receptor Function and Uterine Growth in Ovariectomized Rats. Environ. Health Perspect, 1995; 103: 574–581.
  • Nephew, K.P., Polek, T.C., and Khan, S.A., Tamoxifen-Induced Proto-oncogene Expression Persists in Uterine Endometrial Epithelium. Endocrinology, 1996; 137: 219–224.
  • Fullerton, F.R., Kushmaul, R.J., Suber, R.L., and Littlefield, N.A., Iinfluence of Oral Administration of Sulfamethazine on Thyroid Hormone Levels in Fischer 344 Rats. J. Toxicol. Environ. Health, 1987; 22: 175–185.
  • Goldstein, J.A., Lin, F.H., Stohs, S.J., Graham, M., Clarke, G., Birnbaum, L., and Lucier, G., The Effects of TCDD on Receptors for Epidermal Growth Factor, Glucocor- ticoid and Estrogen in Ah-Responsive and - Nonresponsive Cogenic Mice and the Effects of TCDD on Estradiol Metabolism in a Liver Tumor Promotion Model in Female Rats. In: Mouse Liver Carinogenesis: Mechanisms and Species Comparisons. New York: Alan R. Liss, Inc., 1990, 187–202.
  • Nebert, D.W., Growth Signal Pathways. Nature, 1990; 247: 709–710.
  • Nebert, D.W., Proposed Role of Drug-Metabolizing Enzymes: Regulation of Steady State Levels of Ligands that Effect Growth, Homeostasis, Differentiation and Neuroen- docrine Functions. Mol. Endocrinol, 1991; 5: 1203–1214.
  • Wilson, J.D., Androgens, In: Gilman A.G. et al., Eds., The Pharmacological Basis ofThera- peutics. Elmsford, NY: Pergamon Press, Inc., 1990, 1423–1430.
  • Bhasin, S., Sikka, S., Fielder, T., Sod- Moriah, U., Levine, H.B., Swerdloff, R.S., and Rajfer, J., Hormonal Effects of Ketoconazole in Vivo in the Male Rat: Mechanism of Action. Endocrinology, 1986; 118: 1229–1232.
  • Daston, G.P., Do Thresholds Exist for Developmental Toxicants? A Review of the Theoretical and Experimental Evidence, In: Kalter, H., Ed., Issues and Reviews in Teratology, Volume 6. New York: Plenum Press, 1993, 169–197.
  • Kohn, M.C., Lucier, G.W., Clark, G.C., Sewall, C., Tritscher, A., and Portier, C.J., A Mechanistic Model of the Effects of Di- oxin on Gene Expression in the Rat Liver. Toxicol. Appl. Pharmacol., 1993; 120: 138154.
  • Andersen, M.E., Mills, J.J., Gargas, M.L., Kedderis, L., Birnbaum, L.S., Neubert, D., and Greenlee, W.F., Modeling Receptor- Mediated Processes with Dioxin: Implications for Pharmacokinetics and Risk Assessment. J. Risk Anal., 1993; 13: 25–36.
  • Katzenellenbogen, J.A., O'Malley, B.W., and Katzenellenbogen, B.S., Tripartite Steroid Hormone Receptor Pharmacology: Interaction with Multiple Effector Sites as a Basis for the Cell- and Promoter-Specific Action of These Hormones. Mol. Endocrinol., 1996; 10: 119–131.
  • Portier, C., Tritscher, A., Kohn, M., Sewall, C., Clark, G., Edler, L., Hoel, D., and Lucier, G., Ligand/Receptor Binding for 2,3,7,8-TCDD: Implications for Risk Assessment. Fundam. Appl. Toxicol, 1993; 20: 4856.
  • Truss, M. and Beato, M., Steroid Hormone Receptors: Interaction with Deoxyribonucleic Acid and Transcription Factors. Endocr. Rev., 1993; 14: 459–479.
  • Bagchi, M.K., Tsai, M.-J., O'Malley, B.W., and Tsai, S.Y., Analysis of the Mechanism of Steroid Hormone Receptor-Dependent Gene Activation in Cell-Free Systems. Endocr. Rev, 1992; 13: 525–535.
  • Landel, C.C., Kushner, P.J., and Greene, G.L., Estrogen Receptor Accessory Proteins: Effects on Receptor-DNA Interactions. Environ. Health Perspect., 1995; 103: 2328.
  • Pratt, W.B. and Toft, D.O., Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones. Endocr. Rev., 1997; 18: 306–360.
  • Wagner, R.L., Apriletti, J.W., McGrath, M.E., West, B.L., Baxter, J.D., and Fletterick, R.J., A Structural Role for Hormone in the Thyroid Hormone Receptor. Nature, 1995; 378: 690–697.
  • Weigel, N.L., Steroid Receptors and their Regulation by Phosphorylation, In: Khan, S.A. and Stancel, G.M., Eds., Protooncogenes and Growth Factors in Steroid Hormone Induced Growth and Differentiation. Boca Raton: CRC Press, 1994, 1–12.
  • O'Malley, B.W., Schrader, W.T., Mani, S., Smith, C., Weigel, N.L., Conneely, O.M., and Clark, J.H., An Alternative Ligand-In- dependent Pathway for Activation of Steroid Receptors. Recent Prog. Horm. Res., 1995; 50: 333–347.
  • Beato, M. and Sanchez-Pancheco, A., Interaction of Steroid Hormone Receptors with the Transcription Initiation Complex. Endocr. Rev., 1996; 17: 587–609.
  • McDonnell, D.P., Vegeto, E., and O'Malley, B.W., Identification of a Negative Regulatory Function for Steroid Receptors. Cell Biol., 1992; 89: 10563–10567.
  • Webb, P., Lopez, G.N., Uht, R.M., and Kushner, P.J., Tamoxifen Activation of the Estrogen Receptor/AP-1 Pathway: Potential Origin for the Cell-Specific Estrogen-Like Effects of Antiestrogens. Mol. Endocrinol., 1995; 9: 443–456.
  • Yang, N.N., Venugopalan, M., Hardikar, S., and Glasebrook, A., Identification of an Estrogen Response Element Activated by Metabolites of 17b-Estradiol and Raloxifene. Science, 1996; 273: 1222–1225.
  • Yang, N.N., Venugopalan, M., Hardikar, S., and Glasebrook, A., Raloxifene Response Needs More Than an Element. Science, 1997; 275: 1245.
  • Khan, S.A., Nephew, K.P., and Wang, H., The jun Protooncogene Family in Uterine Growth and Differentiation, In: Khan, S.A. and Stancel, G.M., Eds., Protooncogenes and Growth Factors in Steroid Hormone Induced Growth and Differentiation. Boca Raton: CRC Press, 1994, 105–124.
  • Paech, K., Webb, P., Kuiper, G.G.J.M., Nilsson, S., Gustafsson, J.-A., Kushner, P.J., and Scanlan, T.S., Differential Ligand Activation of Estrogen Receptors ERa and ERb at AP1 Sites. Science, 1997; 277: 15081510.
  • Katzenellenbogen, J.A., The Structural Pervasiveness of Estrogenic Activity. Environ. Health Perspect, 1995; 103: 99–101.
  • Jordan, V.C., Mittal, S., Gosden, B., Koch, R., and Lieberman, M.E., Structure-Activity Relationships of Estrogens. Environ. Health Perspect, 1985; 61: 97–110.
  • Barlow, R.B., Quantitative Aspects ofChemi- cal Pharmacology, Baltimore: University Park Press, 1980.
  • Allan, G.F., Leng, X., Tsai, S.Y., Weigel, N.L., Edwards, D.P., Tsai, M.-J., and O'Malley, B.W., Hormone and Antihormone Induce Distinct Conformational Changes Which Are Central to Steroid Receptor Activation. J. Biol. Chem., 1992; 267: 1951319520.
  • Makela, S., Santti, R., Salo, L., and McLachlan, J.A., Phytoestrogens Are Partial Estrogen Agonists in the Adult Male Mouse. Environ. Health Perspect., 1995; 103: 123–127.
  • Whitten, P.L., Lewis, C., Russell, E., and Naftolin, F., Potential Adverse Effects of Phytoestrogens. J. Nutr, 1995; 125: 771S- 776S.
  • Hyder, S.M., Chiappetta, C., Murthy, L., and Stancel, G.M., Selective Inhibition of Estrogen-Regulated Gene Expression in Vivo by the Pure Antiestrogen ICI 182,780. Cancer Res., 1997; 57: 2547–2549.
  • Katzenellenbogen, B.S. and Gorski, J., Estrogen Actions on Syntheses of Macromol- ecules in Target Cells, In: Litwock, G., Ed., Biochemical Actions ofHormones. New York: Academic Press, 1975, 187–243.
  • Pentecost, B.T., Mattheiss, L., Dickerman, H.W., and Kuman, S.A., Estrogen Regulation of Creatine Kinase-B in the Rat Uterus. Mol. Endocrinol, 1990; 4: 1000–1010.
  • VanderKuur, J.A., Wiese, T., and Brooks, S.C., Influence of Estrogen Structure on Nuclear Binding and Progesterone Receptor Induction by the Receptor Complex. Biochemistry, 1993; 32: 7002–7008.
  • VanderKuur, J.A., Hafner, M.S., Christman, J.K., and Brooks, S.C., Effects of Estradiol-17b Analogues on Activation of Estrogen Response Element Regulated Chloramphenicol Aceyltransferase Expression. Biochemistry, 1993; 32: 70167021.
  • Pilat, M.J., Hafner, M.S., Kral, L.G., and Brooks, S.C., Differential Induction of pS2 and Cathepsin D mRNAs by Structurally Altered Estrogens. Biochemistry, 1993; 32: 7009–7015.
  • Mendel, C.M., The Free Hormone Hypothesis: Distinction from the Free Hormone Transport Hypothesis. J. Androl., 1992; 13: 107–116.
  • Pardridge, W.M., Serum Bioavailability of Sex Steroid Hormones. Clin. Endocrinol. Metab., 1986; 15: 259–279.
  • Siiteri, P.K. and Simberg, N.H., Changing Concepts of Active Androgens in Blood. Clin. Endocrinol. Metab, 1986; 15: 247–258.
  • Gonzales-Cadavid, N.F., Vernet, D., Navarro, A.F., Rodriguez, J.A., Swerdloff, R.S., and Rajfer, J., Up-regulation of the Levels of Androgen Receptor and its mRNA by Androgens in Smooth-Muscle Cells from Rat Penis. Mol. Cell. Endocrinol., 1993; 90: 219–229.
  • Hsueh, A.J.W., Peck, E.J., Jr., and Clark, J.H., Control of Uterine Estrogen Receptor Levels by Progesterone. Endocrinology, 1976; 98: 438–444.
  • Janne, O., Isomaa, V., Isotalo, H., Kokko, E., and Vierikko, P., Uterine Estrogen and Progestin Receptors and Their Regulation. Upsala J. Med. Sci., 1978 62-70.
  • Krause, W.L. and Katzenellenbogen, B.S., Regulation of Progresterone Receptor Gene Expression and Growth in the Rat Uterus: Modulation of Estrogen Actions by Progesterone and Sex Steroid Hormone Antagonists. Endocrinology, 1993; 132: 2371–2379.
  • Medlock, K.L., Lyttle, C.R., Kelepouris, N., Newman, E.D., and Sheehan, D.M., Estradiol Down-Regulation of the Rat Uterine Estrogen Receptor. Proc. Soc. Exp. Biol. Med, 1991; 196: 293–300.
  • Casper, R.F., Regulation of Estrogen/ Progestogen Receptors in the Endometrium. Int. J. Fertil., 1996; 41: 16–21.
  • O'Flaherty, E.J., Physiologically Based Phar- macokinetic Models in Developmental Toxicology. Risk Anal., 1994; 14: 605–611.
  • Kavlock, R.J. and Setzer, R.W., The Road to Embryologically Based Dose-Response Models. Environ. Health Perspect., 1996; 104: 107–121.
  • Shuey, D.L., Lau, C., Logsdon, T.R., Zucker, R.M., Elstein, K.H., Narotsky, M.G., Setzer, R.W., Kavlock, R.J., and Rogers, J.M., Biologically Based Dose-Response Modeling in Developmental Toxicology: Biochemical and Cellular Sequelae of 5-Fluorouracil Exposure in the Developing Rat. Toxicol. Appl. Pharmacol., 1994; 126: 129–144.
  • Lau, C., Klinefelter, G., and Cameron, A.M., Reproductive Development and Functions in the Rat after Repeated Maternal Deprivation Stress. Fundam. Appl. Toxicol, 1996; 30: 398–301.
  • Dixon, R.L., Toxic Responses of the Reproductive System. In: Klaassen, C.D., Amdur, M.O. and Doull, J., Eds. Casarett and Doull's Toxicology: The Basic Science of Poisons, Third Edition. New York: McMillan Publishing Co., 1986, 432–477.
  • Cooper, R.L. and Kavlock, R.J., Endocrine Disruptors and Reproductive Development: A Weight-of-Evidence Overview. J. Endocrinol., 1997; 152: 159–166.
  • Goldman, J.M., Stoker, T.E., Cooper, R.L., McElroy, W.K., and Hein, J.F., Blockage of Ovulation in the Rat by the Fungicide Sodium N-Methyldithiocarbamate: Relationship between Effects on the Luteinizing Hormone Surge and Alterations in Hypothalamic Cat- echolamines. Neurotoxicol. Teratol., 1994; 16: 257–268.
  • Baulieu, E.E. and Robel, P., Neurosteroids: A New Brain Function? In: Hochberg, R.B. and Naftolin, F., Eds., The New Biology of Steroid Hormones. New York: Raven Press, 1991, 251–264.
  • Stoker, T.E., Goldman, J.M., and Cooper, R.L., The Dithiocarbamate Fungicide Thiram Disrupts the Hormonal Control of Ovulation in the Female Rat. Reprod. Toxicol, 1993; 7: 211–218.
  • Uphouse, L., Effects of Chlordecone on Neu- roendocrine Function in Female Rats. NeuroToxicology, 1985; 6: 91–210.
  • Flaws, J.A., Salyers, K.L., Sipes, I.G., and Hoyer, P.B., Reduced Ability of Rat Preantral Ovarian Follicles to Metabolize 4-Vinyl-1- cyclohexene Diepoxide in Vitro. Toxicol. Appl. Pharmacol, 1994; 126: 286–294.
  • Whorton, D., Krauss, R.M., Marshall, S., and Milby, T.H., Infertility in Male Pesticide Workers. Lancet, 1977; 2: 1259–1261.
  • Crawford, M. and Wilson, R., Low-Dose Linearity: The Rule or the Exception? Hum. Ecol. Risk Assess., 1996; 2: 305–330.
  • Pease, W., Vandenburg, J., and Hooper, K., Comparing Alternative Approaches to Establishing Regulatory Levels for Reproductive Toxicants DBCP as a Case Study. Environ. Health Perspect, 1991; 91: 141–155.
  • Meikle, A.W., Benson, S.J., Liu, X.-H., Boam, W.D., and Stringham, J.D., Non- esterified Fatty Acids Modulate Steroidogen- esis in Mouse Leydig Cells. Am. J. Physiol, 1989; 257: E937-E942.
  • Meikle, Q.W., de Sousa, J.C.C., Hanzalova, J., and Murray, D.K., Oleic Acid Inhibits Cholesteryl Esterase and Cholesterol Utilization for Testosterone Synthesis in Mouse Leydig Cells. Metabolism, 1996; 45: 293–299.
  • Gearhart, J.M., Seckel, C., and Vinegar, A., In Vivo Metabolism of Chloroform in B6C3F1 Mice Determined by the Method of Gas Uptake: The Effects of Body Temperature on Tissue Partition Coefficients and Metabolism. Toxicol. Appl. Pharmacol., 1993; 119: 258–266.
  • Terry, K.K., Elswick, B.A., Welsch, F., and Conolly, R.B., Development of a Physiologically Based Pharmacokinetic Model Describing 2-Methyoxyacetic Acid Disposition in the Pregnant Mouse. Toxicol. Appl. Pharmacol., 1995; 132: 103–114.
  • Sakiyama, R., Pardridge, W.M., and Musto, N.A., Influx of Testosterone-Binding Globulin TeBG. and TeBG-Bound Sex Steroid Hormones into Rat Testis and Prostate. J. Clin. Endocrinol. Metab, 1988; 67: 98–103.
  • Brown, J.R. and Shockley, P., Serum Albumin: Structure and Characterization of Its Ligand Binding Sites, In: Jost, P.C. and Griffith, O.H., Eds., Lipid Protein Interactions. New York: John Wiley & Sons, 1982, 25–68.
  • Carlson, K.E. and Katzenellenbogen, J.A., A Comparative Study of the Selectivity and Efficiency of Target Tissue Uptake of Five Tritium-Labeled Androgens in the Rat. J. Steroid. Biochem., 1990; 36: 549–561.
  • Katzenellenbogen, J.A., Mathias, C.J., Vanbrocklin, H.F., Brodack, J.W., and Welch, M.J., Titration of the In Vivo Uptake of 16a-[18F]Fluoroestradiol by Target Tissues in the Rat: Competition by Tamoxifen, and Implications for Quantitating Estrogen Receptors In Vivo and the Use of Animal Models in Recptor-Binding Radiopharmaceutical Development. Nucl. Med. Biol., 1993; 20: 735–745.
  • Jensen, E.V. and Jacobson, H.I., Basic Guides to the Mechanism of Estrogen Action. Recent Prog. Horm. Res, 1962; 18: 387–414.
  • Jensen, E.V., Jacobson, H.I., Flesher, J.W., Saha, N.N., Gupta, G.N., Smith, S., Colucci, V., Shiplacoff, D., Neumann, H.G., DeSombre, E.R., and Jungblut, P.W., Estrogen Receptors in Target Tissues, In: Pincus, G., Nakao, T. and Tait, J.F., Eds., Steroid Dynamics. New York: Academic Press, 1966, 133–157.
  • Clark, J.H., Hardin, J.W., and McCormack, S.A., Mechanism of Action of Estrogen Agonists and Antagonists. J. Anim. Sci., 1979; 49: 46–65.
  • Hammond, G.L., Lahteenmaki, P.L.A., Lahteenmaki, P., and Luukkainen, T., Distribution and Percentages of Non-Protein Bound Contraceptive Steroids in Human Serum. J. SteroidBiochem., 1982; 17: 375–380.
  • Rosner, W., Hryb, D.J., Khan, M.S., Nakhla, A.M. and Romas, N.A., Receptors for Sex Hormone-Binding Globulin: Control of the Interaction and Effects on cAMP. In: Hochberg, R.B. and Naftolin, F., Eds., The New Biology ofSteroid Hormones. New York: Raven Press, 1991, 169–176.
  • Rosner, W., Hryb, D.J., Khan, M.S., Nakhla, A.M., and Romas, N.A., Sex Hormone-Binding Globulin: Anatomy and Physiology of a New Regulatory System. J. Steroid Biochem.. Mol. Biol., 1991; 40: 813–820.
  • Danzo, B.J., Pavlou, S.N., and Anthony, H.L., Hormonal Regulation of Androgen- Binding Protein in the Rat. Endocrinology, 1990; 127: 2829–2838.
  • Nagel, S.C., vom Saal, F.S., Thayer, K.A., Dhar, M.G., Boechler, M., and Welshons, W.V., Relative Binding Affinity-Serum Modified Access RBA-SMA. Assay Predicts the Relative In Vivo Bioactivity of the Xenoestrogens Bisphenol A and Octylphenol. Environ. Health Perspect., 1997; 105: 70–76.
  • Arnold, S.F., Robinson, M.K., Notides, A.C., Guillette, L.J., Jr., and McLachlan, J.A., A Yeast Estrogen Screen for Examining the Relative Exposure of Cells to Natural and Xenoestrogens. Environ. Health Perspect., 1996; 104: 544–548.
  • vom Saal, F.S., Nagel, S.C., Palanza, P., Boechler, M., Parmigiani, S., and Welshons, W.V., Estrogenic Pesticides: Binding Relative to Estradiol in MCF-7 Cells and Effects of Exposure During Fetal Life on Subsequent Territorial Behaviour in Male Mice. Toxicol. Lett., 1995; 77: 343–350.
  • Peck, E.J., Jr., Burgner, J., and Clark, J.H., Estrophilic Binding Sites of the Uterus. Relation to Uptake and Retention of Estradiol in Vitro. Biochemistry, 1973; 12: 4596–4603.
  • Greenstein, B.D., Effects of Rat a-Fetopro- tein Administration on Estradiol Free Fraction, the Onset of Puberty, and Neural and Uterine Nuclear Estrogen Receptors. Endocrinology, 1992; 130: 3184–3190.
  • Korach, K.S., Fox-Davies, C., Quarmby, V.E., and Swaisgood, M.H., Diethylstibestrol Metabolites and Analogs. J. Biol. Chem., 1985; 260: 15420–15426.
  • Stack, G. and Gorski, J., Estrogen-Stimulated Deoxyribonucleic Acid Synthesis: A Ratchet Model for the Prereplicative Period. Endocrinology, 1985; 117: 2017–2023.
  • Jensen, E.V., Metabolic Fate of Sex Hormones in Target Tissues with Regard to Tissue Specificity. In: Proceedings of Second International Congress of Endocrinology. 1965. Amsterdam: Excerpta Medica Foundation.
  • Katzenellenbogen, B.S., Biology and Receptor Interactions of Estriol and Estriol Derivatives In Vitro and In Vivo. J. Steroid Biochem., 1984; 20: 1033–1037.
  • Anderson, J.N., Peck, E.J., Jr., and Clark, J.H., Nuclear Receptor-Estrogen Complex: Relationship Between Concentration and Early Uterotrophic Responses. Endocrinology, 1973; 92: 1488–1495.
  • Anderson, J.N., Peck, E.J., Jr., and Clark, J.H., Estrogen-Induced Uterine Responses and Growth: Relationship to Receptor Estrogen Binding by Uterine Nuclei. Endocrinology, 1975; 96: 160–167.
  • Martin, L., Pollard, J.W., and Fagg, B., Oestrol, Oestradiol-17b and the Proliferation and Death of Uterine Cells. J. Endocrinol., 1976; 69: 103–115.
  • Shapiro, D.J., Barton, M.C., McKearin, D.M., Chang, T.-C., Lew, D., Blume, J., Nielsen, D.A. and Gould, L., Estrogen Regulation of Gene Transcription and mRNA Stability. Recent Prog. Horm. Res., 1989; 45.
  • Sloop, T.C. and Lucier, G.W., Dose- Dependent Elevation of Ah Receptor Binding by TCDD in Rat Liver. Toxicol. Appl. Pharmacol, 1987; 88: 329–337.
  • Tata, J.R., Baker, B.S., Machuca, I., Rabelo, E. M.L., and Yamauchi, K., Autoinduction of Nuclear Receptor Genes and Its Significance. J. Steroid Biochem. Mol. Biol., 1993; 46: 105–119.
  • Andersen, M.E. and Barton, H.A., Switching Characteristics Inherent to Transcriptional Activators Will Lead to Non-Linear Dose Response Relationships for Many Endocrine Active Compounds—EACs. Toxicology, 1998; submitted.
  • Kohn, M.C., Biochemical Mechanisms and Cancer Risk Assessment Models for Dioxin. Toxicology, 1995; 102: 133–138.
  • Andersen, M.E., Birnbaum, L.S., Barton, H.A., and Eklund, C., Regional Hepatic CYP1A1 and CYP1A2 Induction with 2,3,7,8- tetrachlorodibenzo-p-dioxin Evaluated with a Multi-Compartment Geometric Model of Hepatic Zonation. Toxicol. Appl. Pharmacol., 1997; 144: 145–155.
  • Andersen, M.E., Eklund, C.R., Mills, J.J., Barton, H.A., and Birnbaum, L.S., A Multi- Compartment Geometric Model of the Liver in Relation to Regional Induction of Cyto- chrome P450s. Toxicol. Appl. Pharmacol., 1997; 144: 135–144.
  • Andersen, M.E., Gargas, M.L., Hays, S.M., Clewell, H.J., III, and Paustenbach, D.J., Estimating Minimally Effective Inducing Doses ED01s. of TCDD in Livers of Rats and Humans Using Physiologically Based Phar- macokinetic Modeling. OrganoHalogen Compounds, 1997; 34: 311–316.
  • Dai, J.L. and Burnstein, K.L., Two Andro- gen Response Elements in the Androgen Receptor Coding Region Are Required for Cell-Specific Up-Regulation of Receptor Messenger RNA. Mol. Endocrinol, 1996; 10: 1582–1594.
  • Gebel, T., Arand, M., and Oesch, F., Induction of the Perioxisome Proliferator Activated Receptor by Fenofibrate in Rat Liver. FEBS, 1992; 309: 37–40.
  • Sucov, H.M., Murakami, K.K., and Evans, R.M., Characterization of an Autoregulated Response Element in the Mouse Retinoic Acid Receptor Type Beta Gene. Proc. Natl. Acad. Sci. USA, 1990; 87: 5392–5396.
  • George, F.W., Russell, D.W., and Wilson, J.D., Feed-Forward Control of Prostate Growth: Dihydrotestosterone Induces Expression of Its Own Biosynthetic Enzyme, Steroid 5a-Reductase. Proc. Natl. Acad. Sci. USA, 1991; 88: 8044–8047.
  • Russell, D.W. and Wilson, J.D., Steroid 5a- Reductase: Two Genes/Two Enzymes. Ann. Rev.. Biochem., 1994; 63: 25–61.
  • Shadel, G.S. and Baldwin, T.O., The Vibrio fischeri LuxR Protein is Capable of Bidirectional Stimulation of Transcription and Both Positive and Negative Regulation of the luxR Gene. J. Bacteriol., 1991; 173: 568–574.
  • Crews, D., Cantu, A.R., and Bergeron, J.M., Temperature and Non-Aromatizable Andro- gens: A Common Pathway in Male Sex Determination in a Turtle with Temperature- Dependent Sex Determination? J. Endocrinol., 1996; 149: 457–463.
  • Nusslein-Volhard, C., Gradients That Organize Embryo Development. Sci. Am, 1996; August: 54-61.
  • Weisburger, J.H. and Williams, G.M., Carcinogen Testing: Current Problems and New Approaches. Science, 1981; 214: 401–407.
  • Korach, K.S. and McLachlan, J.A., Techniques for Detection of Estrogenicity. Environ. Health Perspect, 1995; 103: 5–8.
  • Soto, A.M., Chung, K.L., and Sonnenschein, C., The Pesticides Endosul- fan, Toxaphene, and Dieldrin Have Estro- genic Effects on Human Estrogen-Sensitive Cells. Environ. Health Perspect., 1994; 102: 308–383.
  • Zacharewski, T., In Vitro Bioassays for Assessing Estrogenic Substances. Environ. Sci. Technol., 1997; 31: 613–623.
  • O'Connor, J.C., Cook, J.C., Craven, S.C., Van Pelt, C.S., and Obourn, J.D., An In Vivo Battery for Identifying Endocrine Modulators That Are Estrogenic or Dopamine Regulators. Fundam. Appl. Toxicol, 1996; 33: 182195.
  • Shelby, M.D., Newbold, R.R., Tully, D.B., K.C., and Davis, V.L., Assessing Environmental Chemicals for Estrogenicity Using a Combination of In Vitro and In Vivo Assays. Environ. Health Perspect, 1996; 104: 12961300.
  • Reel, J.R., James C. Lamb, I., and Neal, B.H., Survey and Assessment of Mammalian Estrogen Biological Assays for Hazard Characterization. Fundam. Appl. Toxicol., 1996; 34: 288–305.
  • Odum, J., Lefevre, P.A., Tittensor, S., Paton, D., Routledge, E.J., Beresford, N.A., Sumpter, J.P., and Ashby, J., The Rodent Uterotrophic Assay: Critical Protocol Features, Studies with Nonyl Phenols, and Comparison with a Yeast Estrogenicity Assay. Regul. Toxicol. Pharmacol, 1997; 25: 176188.
  • Cook, J.C., Kaplan, A.M., Davis, L.G., and O'Connor, J.C., Development of a Tier I Screening Battery for Detecting Endocrine- Active Compounds EACs.. Regul. Toxicol. Pharmacol, 1997; 26: 60–68.
  • Frazier, J.M., Scientific Criteria for Validation of In Vitro Toxicity Tests. The Organization for Economic Co-operation and Development. 1990.
  • EPA, Guidelines for Neurotoxicity Risk Assessment. Fed. Regist., 1995; 60: 5203252056.
  • Waller, C.L., Minor, D.L., and McKinney, J.D., Using Three-Dimensional Quantitative Structure-Activity Relationships to Examine Estrogen Receptor Binding Affinities of Poly- chlorinated Hydroxybiphenyls. Environ. Health Perspect, 1995; 103: 702–707.
  • Sharpe, R.M., Regulation of Spermatogen- esis, In: Knobil, E. and Neill, J.D., Eds., The Physiology of Reproduction. New York: Raven Press, Ltd., 1994, 1363–1434.
  • Rogers, K.R. and Gerlach, C.L., Environmental Biosensors: A Status Report. Environ. Sci. Technol., 1996; 30: 486–491.
  • Zysk, J.R., Johnson, B., Ozenberger, B.A., Bingham, B., and Gorski, J., Selective Uptake of Estrogenic Compounds by Saccharo- myces Cerevisiae: A Mechanism for Anti- estrogen Resistance in Yeast Expressing the Mammalian Estrogen Receptor. Endocrinology, 1995; 136: 1323–1326.
  • Skinner, M.K., McLachlan, R.I., and Bremner, W.J., Stimulation of Sertoli Cell Inhibin Secretion by the Testicular Paracrine Factor PModS. Mol. Cell. Endocrinol., 1989; 66: 239–249.
  • Whaley, P.D., Chaudhary, J., Cupp, A., and Skinner, M.K., Role of Specific Response Elements of the c-fos Promoter and Involvement of Intermediate Transcription Factors. in the Induction of Sertoli Cell Differentiation Transferrin Promoter Activation. by the Testicular Paracrine Factor PModS. Endocrinology, 1995; 136: 3046–3053.
  • Frazier, J.M., Applications of In Vitro Systems to the Prediction of In Vivo Biokinetics. Toxicol. in Vitro, 1995; 9: 527–536.
  • Clewell, H., Gentry, P., Gearhart, J., Allen, B., and Andersen, M., Considering Pharma- cokinetic and Mechanistic Information in Cancer Risk Assessments for Environmental Contaminants: Examples with Vinyl Chloride and Trichloroethylene. Chemosphere, 1995; 31: 2561–2578.
  • Kedderis, G.L., Carfagna, M.A., Held, S.D., Batra, R., Murphy, J.E., and Gargas, M.L., Kinetic Analysis of Furan Biotransformation by F-344 Rats in Vivo and in Vitro. Toxicol. Appl. Pharmacol., 1993; 123: 274–282.
  • Krishnan, K. and Brodeur, J., Toxicologi- cal Consequences of Combined Exposure to Environmental Pollutants. Arch. Complex Environ. Studies, 1991; 3: 1–106.
  • EPA, Guidelines for Health Risk Assessment of Chemical Mixtures. Fed. Regist., 1986; 51: 34014.
  • RPR, "Zero Risk" Era Ends as Congress Adopts "Safe" Pesticides Policy. Risk Policy Report, 1996; 1-5.
  • Konemann, W.H. and Pieters, M., Confusion of Concepts in Mixture Toxicology. Food Chem Toxicol, 1996; 34: 1025–1031.
  • Davis, D. and Safe, S., Dose-Response Immunotoxicities of Commercial Polychlori- nated Biphenyls PCBs. and Their Interaction with 2,3,7,8-Tetrachlorodibenzo-p-dioxin. Toxicol. Lett, 1989; 48: 35–43.
  • Haake, J.M., Safe, S., Mayura, K., and Phillips, T.D., Aroclor 1254 as an Antagonist of the Teratogenicity of 2,3,7,8- Tetrachlorodibenzo-p-dioxin. Toxicol. Lett., 1987; 38: 299–306.
  • Narotsky, M.G., Weller, E.A., Chinchilli, V.M., and Kavlock, R.J., Nonadditive Developmental Toxicity in Mixtures of Trichlo- roethylene Di2-ethylhexyl. Phthalate, and Heptachlor in a 5 x 5 x 5 Design. Fundam. Appl. Toxicol., 1995; 27: 203–216.
  • Korach, K.S., Chae, K., Gibson, M., and Curtis, S., Estrogen Receptor Stereochemistry: Ligand Binding and Hormonal Responsiveness. Steroids, 1991; 56: 263–270.
  • Ramamoorthy, K., Wang, F., Chen, I.-C., Safe, S., Norris, J.E., McDonnell, D.P., Gaido, K.W., Bocchinfuso, W.P., and Korach, K.S., Potency of Combined Estro- genic Pesticides. Science, 1997; 275: 405406.
  • Arnold, S.F., Klotz, D.M., Collins, B.M., Vonier, P.M., Guillette, L.J., Jr., and McLachlan, J.A., Synergistic Activation of Estrogen Receptor with Combinations of Environmental Chemicals. Science, 1996; 272: 1489–1492.
  • McLachlan, J.A., Synergistic Effect of Environmental Estrogens: Report Withdrawn. Science, 1997; 277: 462–463.
  • Bergeron, J.M., Crews, D., and McLachlan, J.A., PCBs as Environmental Estrogens: Turtle Sex Determination as a Biomarker of Environmental Contamination. Environ. Health Perspect, 1994; 102: 708–781.
  • Cho, H. and Katzenellenbogen, B.S., Syn- ergistic Activation of Estrogen Receptor- Mediated Transcription by Estradiol and Protein Kinase Activators. Mol. Endocrinol., 1993; 7: 441–452.
  • Zhao, X.Y., Ly, L.H., Peehl, D.M., and Feldman, D., 1a,25-Dihydroxyvitamin D3 Actions in LNCaP Human Prostate Cancer Cells Are Androgen-Dependent. Endocrinology, 1997; 138: 3290–3298.
  • Kaiser, J., Scientists Angle for Answers. Science, 1996; 274: 1837–1838.
  • Baker, M.E., Endocrine Activity of Plant- Derived Compounds: An Evolutionary Perspective. Proc. Soc. Exp. Biol. Med., 1995; 208: 131–138.
  • Crump, K.S., Hoel, D.G., Langley, C.H., and Peto, R., Fundamental Carcinogenic Processes and Their Implications for Low Dose Risk Assessment. Cancer Res., 1976; 36: 29732979.
  • vom Saal, F.S., Even, M.D., and Quadagno, D.M., Effects of Maternal Stress on Puberty, Fertility and Aggressive Behavior of Female Mice from Different Intrauterine Positions. Physiol. Behav., 1991; 49: 1073–1078.
  • Turturro, A., Blank, K., Murasko, D., and Hart, R., Mechanisms of Caloric Restriction Affecting Aging and Disease. Ann. NY Acad. Sci., 1994; 719: 159–170.
  • Rogers, A.E., Zeisel, S.H., and Groopman, J., Diet and Carcinogenesis. Carcinogenesis, 1993; 14: 2205–2217.
  • Chapin, R.E. and Gulati, D.K., Feed Restriction in Rats. Environ. Health Perspect., 1997; 105: 381–382.
  • Chapin, R.E. and Gulati, D.K., Feed Restriction in Swiss CD-1 Mice. Environ. Health Perspect., 1997; 105: 377–378.
  • Heindel, J.J. and Fail, P.A., Feed Restriction in Swiss CD-1Mice. Environ. Health Perspect., 1997; 105: 379–380.
  • NRC, Drinking Water and Health, Volume 6, Thomas, R.D., Ed., Washington, D.C.: National Academy Press, 1986.
  • Clewell, H.J., The Application of Physiologically Based Pharmacokinetic Modeling in Human Health Risk Assessment of Hazardous Substances. Toxicol. Lett, 1995; 79: 207–217.
  • Kavlock, R.J. and Ankley, G.T., A Perspective on the Risk Assessment Process for Endocrine-Disruptive Effects on Wildlife and Human Health. Risk Anal., 1996; 16: 731739.
  • EPA, Guidelines for Developmental Toxicity Risk Assessment. Fed. Regist., 1991; 56: 63798–63826.
  • Jarabeck, A.M., Interspecies Extrapolation Based on Mechanistic Determinants of Chemical Disposition. Hum. Ecol. Risk Assess., 1995; 1: 641–662.
  • EPA, Exposure Factors Handbook,, EPA 600/ 6-89/043, Washington, D.C.: Office of Health and Environmental Assessment, 1989.
  • EPA, Guidelines for Exposure Assessment. Fed. Regist, 1992; 57: 22888–22938.
  • EPA, Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry, EPA/600/8-90/066F, Washington, D.C.: Office of Research and Development, 1994.
  • EPA, The Use of the Benchmark Dose Approach in Health Risk Assessment, EPA/630/R-94/007, Washington, D.C.: US Environmental Protection Agency, 1995.
  • Dourson, M.L., Methods for Establishing Oral Reference Doses, In: Mertz, W., Abernathy, C.O., and Olin, S.S., Eds., Risk Assessment of Essential Elements. Washington, DC: ILSI Press, 1994, 51–61.
  • Renwick, A.G., Safety Factors and the Establishment of ADI. Food Add. Contam., 1991; 8: 135–150.
  • EPA, Thyroid Follicular Cell Carcinogenesis: Mechanistic and Science Policy Considerations, EPA/625/3-88/014A, Washington, D.C.: Environmental Protection Agency, 1988.
  • Conolly, R.B. and Andersen, M.E., Quantitative Analysis of Dose-Response Data for Tetrachlorodibenzo-p-dioxin: Hepatic Foci in Rats after Diethylnitrosamine Initiation. Toxicol. Appl. Pharmacol, 1997: 281-293.
  • Schmidt, C.W., The ABCs of Protecting Kids. Environ. Health Perspect., 1997; 105: 702703.
  • NRC, Pesticides in the Diets of Children and Infants, Washington, D.C.: NAS Press, 1993.
  • Andersen, M.E., Clewell, H.J., Jr., and Frederick, C.B., Applying Simulation Modeling to Problems in Toxicology and Risk Assessment—A Short Perspective. Toxicol. Appl. Pharmacol., 1995; 133: 181187.
  • Conolly, R.B., Reitz, R.H., Clewell, H.J., and Andersen, M.E., Biologically Structured Models and Computer Simulation. Comm. Toxicol., 1988; 2: 305–319.
  • Kavlock, R.J., Recent Advances in Mathematical Modeling of Developmental Abnormalities Using Mechanistic Information. Reprod. Toxicol., 1997; 11: 423–434.
  • Clewell, H.J., Incorporating Biological Information in Quantitative Risk Assessment: An Example with Methylene Chloride. Toxicology, 1995; 102: 83–94.
  • Gerlowski, L.E. and Jain, R.K., Physiologically Based Pharmacokinetic Modeling: Principles and Applications. J. Pharm. Sci., 1983; 72: 1103–1124.
  • Corley, R.A., Bormett, G.A., and Ghanayem, B.I., Physiologically Based Phar- macokinetics of 2-Butoxyethanol and Its Major Metabolite, 2-Butoxyacetic Acid, in Rats and Humans. Toxicol. Appl. Pharmacol., 1994; 129: 61–79.
  • Fisher, J.W., Whittaker, T.A., Taylor, D.H., Clewell, H.J., III, and Andersen, M.E., Physiologically Based Pharmacokinetic Modeling of the Lactating Rat and Nursing Pup: A Multiroute Exposure Model for Trichloroeth- ylene and Its Metabolite, Trichloroacetic Acid. Toxicol. Appl. Pharmacol., 1990; 102: 497513.
  • Gaylor, D.W. and Razzaghi, M., Process of Building Biologically Based Dose Response Models for Developmental Defects. Teratology, 1992; 46: 573–581.
  • Luecke, R.H., Wosilait, W.D., Pearce, B.A., and Young, J.F., A Physiologically Based Pharmacokinetic Computer Model for Human Pregnancy. Teratology, 1994; 49: 90103.
  • Carson, E.R., Cobelli, C., and Finkelstein, L., The Mathematical Modeling of Metabolic and Endocrine Systems. Model Formulation, Identification, and Validation, New York: John Wiley & Sons, 1983.
  • Himmelstein, K.J. and Lutz, R.J., A Review of the Applications of Physiologically Based Pharmacokinetic Modeling. J. Pharma- cokinet. Biopharm, 1979; 7: 127–145.
  • Bois, F.Y., Woodruff, T.J., and Spear, R.C., Comparison of Three Physiologically Based Pharmacokinetic Models of Benzene Disposition. Toxicol. Appl. Pharmacol, 1991; 110: 19–88.
  • Clewell, H.J., III, Lee, T., and Carpenter, R.L., Sensitivity of Physiologically Based Pharmacokinetic Models to Variation in Model Parameters: Methylene Chloride. Risk Anal, 1994; 14: 521–531.
  • Hattis, D. and Barlow, K., Human Interindividual Variability in Cancer Risks— Technical and Management Challenges. Hum. Ecol. Risk Assess., 1996; 2: 194–220.
  • Hattis, D., Erdreich, L., and Ballew, M., Human Variability in Susceptibility to Toxic Chemicals—A Preliminary Analysis of Phar- macokinetic Data from Normal Volunteers. Risk Anal., 1987; 7: 415–426.
  • Hattis, D. and Silver, K., Human Interindividual Variability—A Major Source of Uncertainty in Assessing Risks for Noncancer Health Effects. Risk Anal., 1994; 14: 421–431.
  • Tukey, J., Ciminera, J., and Heyse, B., Testing the Statistical Certainty of a Response to Increasing Dose of a Drug. Biometrics, 1985; 41: 295–301.
  • Kavlock, R.J., Allen, B.C., Faustman, E.M., and Kimmel, C.A., Dose-Response Assessments for Developmental Toxicity IV. Benchmark Doses for Fetal Weight Changes. Fundam. Appl. Toxicol, 1995; 26: 211–222.
  • Crump, K.S., A New Method for Determining Allowable Daily Intakes. Fundam. Appl. Toxicol., 1984; 4: 854–871.
  • Crump, K.S., Calculation of Benchmark Doses from Continuous Data. Risk Anal., 1995; 15: 79–89.
  • Gaylor, D.W. and Slikker, W., Jr., Risk Assessment for Neurotoxic Effects. Neuro- toxicology, 1990; 11: 211–218.
  • EPA, Workshop Report on Toxicity Equivalency Factors for Polychlorinated Biphenyl Congeners, EPA/625/3-91/020, Washington, D.C.: US Environmental Protection Agency, 1991.
  • EPA, Provisional Guidance for Quantitative Risk Assessment of Polycyclic Armomatic Hydrocarbons, EPA-600-R-93/089, Washington, D.C.: Office of Health and Environmental Assessment, 1993.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.